Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Argutus Medical’s AKI Test Selected for Innovators Place™

Published: Thursday, October 25, 2012
Last Updated: Thursday, October 25, 2012
Bookmark and Share
Specialists in organ injury present RenaStat at ASN Kidney Week 2012.

Argutus Medical has been chosen as one of ten companies to display their latest product at the Innovators Place™ during the American Society of Nephrology (ASN) Kidney Week 2012.

The scientific exposition, which takes place from the 1st to the 4th of November at the San Diego Convention Center, USA, will bring together more than 13,000 professionals from around the globe to learn the latest scientific and medical advances in the field of kidney function and disease. InnovatorsEKF-Diagnostics.gif Place™ will be located in the Kidney Week exhibit hall (Halls A-B-C) in a dedicated exhibition space that provides the opportunity for scientific networking between medical device industry trendsetters and the nephrology community.

At the Innovators Place™, Argutus Medical, a subsidiary of EKF Diagnostics (AIM listed worldwide manufacturer of point-of-care diagnostic tools, organ injury biomarkers and assays) will showcase its new point-of-care test, the RenaStat. Renastat has been developed to detect the early onset of severe acute kidney injury (AKI) in critical care settings. Argutus’ team of AKI experts will provide attendees with an insight into the RenaStat test, as well as scientific information on the development and use of biomarkers for AKI detection.

RenaStat combines novel microfluidic and magnetic immuno-chromatographic technologies (MICT) to allow accurate detection of alpha and pi glutathione S-Transferase (GSTs) in less than 15 minutes from 100µl of patient urine. This rapid, early assessment of biomarkers enables clinicians to promptly identify and carry out appropriate patient treatment.

"Being selected to showcase at such a high profile meeting as Kidney Week 2012, is a privilege and testament to the hard work that has gone into developing RenaStat through years of research and development. Argutus representatives will be on hand to discuss with our renal medicine colleagues how the application of RenaStat can improve patient diagnosis and treatment" said Joe Keenan, General Manager at Argutus.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

EKF Diagnostics’ Growth Drives New Role Creation
Expanding business welcomes new faces to further strengthen IVD expertise and new product development.
Saturday, July 18, 2015
EKF Diagnostics Collaborates with Joslin Diabetes Center
Supporting the ongoing clinical and commercial development of early Diabetic Kidney Disease biomarkers.
Monday, November 17, 2014
Studies Validate EKF Diagnostics’ Early Stage Test for Progressive DKD
Independent scientific evidence confirms novel sTNFR1/2 biomarkers can accurately predict end-stage renal disease, up to 10 years in advance.
Friday, May 23, 2014
New Clinical Diagnostics Distributor Program Enhances EKF Customer Service
EKF Diagnostics appoints Simona Carnielli as new EMEA Distribution Manager.
Thursday, May 08, 2014
EKF Diagnostics Acquires Selah Genomics and DiaSpect Medical
Combined with the recent acquisition of Seperation Technology the purchases strengthen EKF’s product and services offering.
Tuesday, April 22, 2014
EKF Diagnostics Acquires Separation Technology
Acquisition complements EKF’s existing offering in the hemoglobin testing market place.
Thursday, March 27, 2014
PointMan™ Enriches Low-level DNA Mutations from Whole Blood
Ultra-sensitive PointMan™ enables blood sampling instead of tissue biopsies for cancer patient mutation status assessment.
Wednesday, January 22, 2014
Scientific News
Will Brain Palpation Soon Be Possible?
Researchers have developed non-invasive brain imaging technique which provides the same information as physical palpation.
Groundbreaking Computer Program Diagnoses Cancer in Two Days
Researchers have combined genetics with computer science and created a new diagnostic technology can with 85 per cent certainty identify the source of the disease and thus target treatment and, ultimately, improve the prognosis for the patient.
Detecting HIV Diagnostic Antibodies with DNA Nanomachines
New research may revolutionize the slow, cumbersome and expensive process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV.
Horse Illness Shares Signs of Human Disease
Horses with a rare nerve condition have similar signs of disease as people with conditions such as Alzheimer’s, a study has found.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
The Age of Humans Controlling Microbes
Engineered bacteria could soon be used to detect environmental toxins, treat diseases, and sustainably produce chemicals and fuels.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos